Managed Healthcare Executive6h
The Power of PBMs and Biosimilars, 2025 Launches of the Stelara Biosimilars, the IRA and Interchangeability | Q&A with Craig Burton, MBA
The second part of our conversation with Craig Burton, MBA, executive director of the Biosimilars Council, a trade and ...
Managed Healthcare Executive12h
Sarepta Announces Positive Results for Elevidys, Gene Therapy for Duchenne
Results show improved functional outcomes for people with Duchenne muscular dystrophy who are ambulatory. Elevidys, which is ...
Managed Healthcare Executive8h
Extra Rituximab Dose at Six Months May Prevent Early Relapse in Pemphigus Patients
Pemphigus is a rare autoimmune disease that causes painful blisters on the skin and mucous membranes, including the mouth, ...
Managed Healthcare Executive10h
David Joyner: CVS Health is on a Pharmacy Transformation Journey
Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...
Managed Healthcare Executive11h
Entrada Therapeutics On Track For New DMD Study in the U.K.
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
Managed Healthcare Executive17h
Updated: CVS Health’s Medical Benefit Ratio Increases But Company Sees Better Path for 2025
CVS Health’s total revenue for the full year 2024 increased 4.2% to $372.8 billion, but within the healthcare benefits ...
Managed Healthcare Executive9h
The Growing Popularity of Non-hormonal Menopause Therapy
Menopausal patients are most interested in learning more about non-hormonal treatments to address their symptoms, according to the results of an international survey led by the Menopause Priority ...